Startseite » Forschung » Publikationen » 50 Bestplazierten Publikationen

Die 50 bestplazierten Publikationen 2000 – 2009

Die öffentliche Wahrnehmung und der Einfluss von Forschern im nationalen und internationalen Wissenschaftswettbewerb ist umso höher, je häufiger es gelingt, Forschungsergebnisse in weit verbreiteten und viel gelesenen Fachzeitschriften zu publizieren.

Die deutsche Forschungsgemeinschaft DFG setzte kürzlich Regeln gegen die Publikationsflut in der Wissenschaft in Kraft. „Qualität statt Quantität“ als Devise. Qualität in der Wissenschaft wird häufig an Indikatoren wie Zitierhäufigkeit oder Publikationshäufigkeit in sog. „high impact journals“ bemessen.

Die Zitierhäufigkeit einer Einzelveröffentlichung steht in Relation zum sog. Impact Factor einer Zeitschrift. Je höher der Impact Factor, desto angesehener ist eine Fachzeitschrift. Dies wirkt sich auch auf die akademische Beurteilung von Wissenschaftlern aus: Wer in Zeitschriften mit höherem Impact Factor publiziert, hat größere Chancen Forschungsgelder einzuwerben, und auch bessere Karrierechancen.

Die Auswahl von Publikationen aus den letzten 10 Jahren auf den folgenden Seiten listet Beiträge der Klinik in Zeitschriften der Kategorie high impact auf und soll den Forschungserfolg der Klinik nach qualitativen Kriterien illustrieren.

 

von Mutius, E.:
Of attraction and rejection--asthma and the microbial world.
N Engl J Med. 357(15), 1545-1547 (2007) - Impact Factor: 52.589.

Renner, E.D., Torgerson, T.R., Rylaarsdam, S., Añover-Sombke, S., Golob, K., LaFlam, T., Zhu, Q., Ochs, H.D.:
STAT3 mutation in the original patient with Job's syndrome.
N Engl J Med. 357(16), 1667-1668 (2007) - Impact Factor: 52.589.

Eder, W., Ege, M.J., von Mutius, E.:
The asthma epidemic.
N Engl J Med. 355(21), 2226-2235 (2006) - Impact Factor: 51.296.

Binder, V., Albert, M.H., Kabus, M., Bertone, M., Meindl, A., Belohradsky, B.H.:
The genotype of the original Wiskott phenotype.
N Engl J Med. 355(17), 1790-1793 (2006) - Impact Factor: 51.296.

Frey, U., von Mutius, E.:
The challenge of managing wheezing in infants.
N Engl J Med. 360(20), 2130-2133 (2009) - Impact Factor: 50.017.

Aiuti, A., Cattaneo, F., Galimberti, S., Benninghoff, U., Cassani, B., Callegaro, L., Scaramuzza, S., Andolfi, G., Mirolo, M., Brigida, I., Tabucchi, A., Carlucci, F., Eibl, M., Aker, M., Slavin, S., Al-Mousa, H., Al Ghonaium, A., Ferster, A., Duppenthaler, A., Notarangelo, L., Wintergerst, U., Buckley, R.H., Bregni, M., Marktel, S., Valsecchi, M.G., Rossi, P., Ciceri, F., Miniero, R., Bordignon, C., Roncarolo, M.G.:
Gene therapy for immunodeficiency due to adenosine deaminase deficiency.
N Engl J Med. 360(5), 447-458 (2009) - Impact Factor: 50.017.

Muntau, A.C., Röschinger, W., Habich, M., Demmelmair, H., Hoffmann, B., Sommerhoff, C.P., Roscher, A.A.:
Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria.
N Engl J Med. 347(26), 2122-2132 (2002) - Impact Factor: 31.736.

Neumann, H.P., Bausch, B., McWhinney, S.R., Bender, B. U., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., Januszewicz, A., Eng, C., Smith, W.M., Munk, R., Manz, T., Glaesker, S., Apel, T.W., Treier, M., Reineke, M., Walz, M.K., Hoang-Vu, C., Brauckhoff, M., Klein-Franke, A., Klose, P., Schmidt, H., Maier-Woelfle, M., Peçzkowska, M., Szmigielski, C.:
Germ-line mutations in nonsyndromic pheochromocytoma.
N Engl J Med. 346(19), 1459-1466 (2002) - Impact Factor: 31.736.

Braun-Fahrländer, C., Riedler, J., Herz, U., Eder, W., Waser, M., Grize, L., Maisch, S., Carr, D., Gerlach, F., Bufe, A., Lauener, R.P., Schierl, R., Renz, H., Nowak, D., von Mutius, E.:
Environmental exposure to endotoxin and its relation to asthma in school-age children.
N Engl J Med. 347(12), 869-877 (2002) - Impact Factor: 31.736.

Hrabé de Angelis, M.H., Flaswinkel, H., Fuchs, H., Rathkolb, B., Soewarto, D., Marschall, S., Heffner, S., Pargent, W., Wuensch, K., Jung, M., Reis, A., Richter, T., Alessandrini, F., Jakob, T., Fuchs, E., Kolb, H., Kremmer, E., Schaeble, K., Rolinski, B., Roscher, A., Peters, C., Meitinger, T., Strom, T., Steckler, T., Holsboer, F., Klopstock, T., Gekeler, F., Schindewolf, C., Jung, T., Avraham, K., Behrendt, H., Ring, J., Zimmer, A., Schughart, K., Pfeffer, K., Wolf, E., Balling, R.:
Genome-wide, large-scale production of mutant mice by ENU mutagenesis.
Nat Genet. 25(4), 444-447 (2000) - Impact Factor: 30.259.

Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A.O., Landthaler, M., Lin, C., Socci, N. D., Hermida, L., Fulci, V., Chiaretti, S., Foà, R., Schliwka, J., Fuchs, U., Novosel, A., Müller, R.U., Schermer, B., Bissels, U., Inman, J., Phan, Q., Chien, M., Weir, D.B., Choksi, R., De Vita, G., Frezzetti, D., Trompeter, H.I., Hornung, V., Teng, G., Hartmann, G., Palkovits, M., Di Lauro, R., Wernet, P., Macino, G., Rogler, C.E., Nagle, J.W., Ju, J., Papavasiliou, F.N., Benzing, T., Lichter, P., Tam, W., Brownstein, M.J., Bosio, A., Borkhardt, A., Russo, J.J., Sander, C., Zavolan, M., Tuschl, T.:
A mammalian microRNA expression atlas based on small RNA library sequencing.
Cell. 129(7), 1401-1414 (2007) - Impact Factor: 29.887.

Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., Morillon, E., Sorensen, R., Forster, A., Fraser, P., Cohen, J.I., de Saint Basile, G., Alexander, I., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, I., Gross, F., Valensi, F., Delabesse, E., Macintyre, E., Sigaux, F., Soulier, J., Leiva, L.E., Wissler, M., Prinz, C., Rabbitts, T.H., Le Deist, F., Fischer, A., Cavazzana-Calvo, M.:
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.
Science. 302(5644), 415-419 (2003) - Impact Factor: 29.162.

Moffatt, M.F., Kabesch, M., Liang, L., Dixon, A. L., Strachan, D., Heath, S., Depner, M., von Berg, A., Bufe, A., Rietschel, E., Heinzmann, A., Simma, B., Frischer, T., Willis-Owen,
S.A., Wong, K.C., Illig, T., Vogelberg, C., Weiland, S.K., von Mutius, E., Abecasis, G.R., Farrall, M., Gut, I.G., Lathrop, G.M., Cookson, W.O.:
Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma.
Nature. 448(7152), 470-473 (2007) - Impact Factor: 28.751.

von Mutius, E.:
Rhinitis as predictor of adult-onset asthma.
Lancet. 372(9643), 1012-1014 (2008) - Impact Factor: 28.409.

Sly, P.D., Boner, A.L., Björksten, B., Bush, A., Custovic, A., Eigenmann, P.A., Gern, J.E., Gerritsen, J., Hamelmann, E., Helms, P.J., Lemanske, R.F., Martinez, F., Pedersen, S., Renz, H., Sampson, H., von Mutius, E., Wahn, U., Holt, P. G.:
Early identification of atopy in the prediction of persistent asthma in children.
Lancet. 372(9643), 1100-1106 (2008) - Impact Factor: 28.409.

Lau, S., Illi, S., Sommerfeld, C., Niggemann, B., Bergmann, R., von Mutius, E., Wahn, U.:
Early exposure to house-dust mite and cat allergens and development of childhood asthma: a cohort study. Multicentre Allergy Study Group.
Lancet. 356(9239), 1392-1397 (2000) - Impact Factor: 28.409.

Beasley, R., Clayton, T., Crane, J., von Mutius, E., Lai, C.K., Montefort, S., Stewart, A., Group, I. P. T. S.:
Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme.
Lancet. 372(9643), 1039-1048 (2008) - Impact Factor: 28.409.

Holt, P.G., Sly, P.D., Martinez, F.D., Weiss, S.T., Björkstén, B., von Mutius, E., Wahn, U.:
Drug development strategies for asthma: in search of a new paradigm.
Nat Immunol. 5(7), 695-698 (2004) - Impact Factor: 27.586.

Aravin, A., Gaidatzis, D., Pfeffer, S., Lagos-Quintana, M., Landgraf, P., Iovino, N., Morris, P., Brownstein, M. ., Kuramochi-Miyagawa, S., Nakano, T., Chien, M., Russo, J.J., Ju, J., Sheridan, R., Sander, C., Zavolan, M., Tuschl, T.:
A novel class of small RNAs bind to MILI protein in mouse testes.
Nature. 442(7099), 203-207 (2006) - Impact Factor: 26.681.

Randak, C., Welsh, M.J.:
An intrinsic adenylate kinase activity regulates gating of the ABC transporter CFTR.
Cell. 115(7), 837-850 (2003) - Impact Factor: 26.626.

Allen, M., Heinzmann, A., Noguchi, E., Abecasis, G., Broxholme, J., Ponting, C.P., Bhattacharyya, S., Tinsley, J., Zhang, Y., Holt, R., Jones, E.Y., Lench, N., Carey, A., Jones, H., Dickens, N.J., Dimon, C., Nicholls, R., Baker, C., Xue, L., Townsend, E., Kabesch, M., Weiland, S.K., Carr, D., von Mutius, E., Adcock, I.M., Barnes, P.J., Lathrop, G.M., Edwards, M., Moffatt, M.F., Cookson, W.O.:
Positional cloning of a novel gene influencing asthma from chromosome 2q14.
Nat Genet. 35(3), 258-263 (2003) - Impact Factor: 26.494.

Hartl, D., Latzin, P., Hordijk, P., Marcos, V., Rudolph, C., Woischnik, M., Krauss-Etschmann, S., Koller, B., Reinhardt, D., Roscher, A.A., Roos, D., Griese, M.:
Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease.
Nat Med. 13(12), 1423-1430 (2007) - Impact Factor: 26.382.

Illi, S., von Mutius, E., Lau, S., Niggemann, B., Grüber, C., Wahn, U., Multicentre Allergy Study,.: Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study.
Lancet. 368(9537), 763-770 (2006) - Impact Factor: 25.800.

Vogt, G., Chapgier, A., Yang, K., Chuzhanova, N., Feinberg, J., Fieschi, C., Boisson-Dupuis, S., Alcais, A., Filipe-Santos, O., Bustamante, J., de Beaucoudrey, L., Al-Mohsen, I., Al-Hajjar, S., Al-Ghonaium, A., Adimi, P., Mirsaeidi, M., Khalilzadeh, S., Rosenzweig, S., de la Calle Martin, O., Bauer, T.R., Puck, J.M., Ochs, H.D., Furthner, D., Engelhorn, C., Belohradsky, B., Mansouri, D., Holland, S.M., Schreiber, R.D., Abel, L., Cooper, D.N., Soudais, C., Casanova, J.L.: 

Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations.
Nat Genet. 37(7), 692-700 (2005) - Impact Factor: 25.797.

Schaub, B., von Mutius, E.:
The marketing of asthma and allergies.
Lancet. 364(9443), 1389-1390 (2004) - Impact Factor: 21.713.

Berweck, S., Schroeder, A.S., Fietzek, U.M., Heinen, F.:
Sonography-guided injection of botulinum toxin in children with cerebral palsy.
Lancet. 363(9404), 249-250 (2004) - Impact Factor: 21.713.

Minegishi, Y., Saito, M., Morio, T., Watanabe, K., Agematsu, K., Tsuchiya, S., Takada, H., Hara, T., Kawamura, N., Ariga, T., Kaneko, H., Kondo, N., Tsuge, I., Yachie, A., Sakiyama, Y., Iwata, T., Bessho, F., Ohishi, T., Joh, K., Imai, K., Kogawa, K., Shinohara, M., Fujieda, M., Wakiguchi, H., Pasic, S., Abinun, M., Ochs, H.D., Renner, E.D., Jansson, A., Belohradsky, B.H., Metin, A., Shimizu, N., Mizutani, S., Miyawaki, T., Nonoyama, S., Karasuyama, H.:
Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity.
Immunity. 25(5), 745-755 (2006) - Impact Factor: 18.306.

Hacein-Bey-Abina, S., Garrigue, A., Wang, G.P., Soulier, J., Lim, A., Morillon, E., Clappier, E., Caccavelli, L., Delabesse, E., Beldjord, K., Asnafi, V., MacIntyre, E., Dal Cortivo, L., Radford, I., Brousse, N., Sigaux, F., Moshous, D., Hauer, J., Borkhardt, A., Belohradsky, B.H., Wintergerst, U., Velez, M.C., Leiva, L., Sorensen, R., Wulffraat, N., Blanche, S., Bushman, F.D., Fischer, A., Cavazzana-Calvo, M.: 

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1.
J Clin Invest. 118(9), 3132-3142 (2008) - Impact Factor: 16.559.

Sträter, R., Becker, S., von Eckardstein, A., Heinecke, A., Gutsche, S., Junker, R., Kurnik, K., Schobess, R., Nowak-Göttl, U.:
Prospective assessment of risk factors for recurrent stroke during childhood--a 5-year follow-up study.
Lancet. 360(9345), 1540-1545 (2002) - Impact Factor: 15.397.

Lauener, R.P., Birchler, T., Adamski, J., Braun-Fahrländer, C., Bufe, A., Herz, U., von Mutius, E., Nowak, D., Riedler, J., Waser, M., Sennhauser, F.H.:
Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children.
Lancet. 360(9331), 465-466 (2002) - Impact Factor: 15.397.

Lee, C.G., Hartl, D., Lee, G.R., Koller, B., Matsuura, H., Da Silva, C.A., Sohn, M.H., Cohn, L., Homer, R.J., Kozhich, A.A., Humbles, A., Kearley, J., Coyle, A., Chupp, G., Reed, J., Flavell, R. A., Elias, J.A.:
Role of breast regression protein 39 /chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis.
J Exp Med. 206(5), 1149-1166 (2009) - Impact Factor: 15.219.

Frommhold, D., Ludwig, A., Bixel, M.G., Zarbock, A., Babushkina, I., Weissinger, M., Cauwenberghs, S., Ellies, L. G., Marth, J.D., Beck-Sickinger, A.G., Sixt, M., Lange-Sperandio, B., Zernecke, A., Brandt, E., Weber, C., Vestweber, D., Ley, K., Sperandio, M.:
Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammation.
J Exp Med. 205(6), 1435-1446 (2008) - Impact Factor: 15.219.

Conrad, M.L., Ferstl, R., Teich, R., Brand, S., Blümer, N., Yildirim, A.O., Patrascan, C.C., Hanuszkiewicz, A., Akira, S., Wagner, H., Holst, O., von Mutius, E., Pfefferle, P.I., Kirschning, C.J., Garn, H., Renz, H.:
Maternal TLR signaling is required for prenatal asthma protection by the nonpathogenic microbe Acinetobacter Iwoffii F78.
J Exp Med. 206(13), 2869-2877 (2009) - Impact Factor: 15.219.

Dames, P., Gleich, B., Flemmer, A., Hajek, K., Seidl, N., Wiekhorst, F., Eberbeck, D., Bittmann, I., Bergemann, C., Weyh, T., Trahms, L., Rosenecker, J., Rudolph, C.:
Targeted delivery of magnetic aerosol droplets to the lung.
Nat Nanotechnol. 2(8), 495-499 (2007) - Impact Factor: 14.917.

Young, G., Albisetti, M., Bonduel, M., Brandao, L., Chan, A., Friedrichs, F., Goldenberg, N.A., Grabowski, E., Heller, C., Journeycake, J., Kenet, G., Krümpel, A., Kurnik, K., Lubetsky, A., Male, C., Manco-Johnson, M., Mathew, P., Monagle, P., van Ommen, H., Simioni, P., Svirin, P., Tormene, D., Nowak-Göttl, U.:
Impact of inherited thrombophilia on venous thromboembolism in children: a systematic review and meta-analysis of observational studies.
Circulation. 118(13), 1373-1382 (2008) - Impact Factor: 14.595.

Jeremias, I., Kupatt, C., Martin-Villalba, A., Habazettl, H., Schenkel, J., Boekstegers, P., Debatin, K.M.: Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia.
Circulation. 102(8), 915-920 (2000) - Impact Factor: 14.595.

Wossning, T., Herzog, S., Köhler, F., Meixlsperger, S., Kulathu, Y., Mittler, G., Abe, A., Fuchs, U., 
Borkhardt, A., Jumaa, H.:
Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells.
J Exp Med. 203(13), 2829-2840 (2006) - Impact Factor: 14.484

Berweck, S.:
BP-DBS for dystonia-choreoathetosis cerebral palsy.
Lancet Neurol. 8(8), 692-693 (2009) - Impact Factor: 14.270.

Yu, X.Z., Albert, M.H., Martin, P.J., Anasetti, C.:
CD28 ligation induces transplantation tolerance by IFN-gamma-dependent depletion of T cells that recognize alloantigens.
J Clin Invest. 113(11), 1624-1630 (2004) - Impact Factor: 14.204.

Lopez Granados, E., Porpiglia, A.S., Hogan, M.B., Matamoros, N., Krasovec, S., Pignata, C., Smith, C.I., Hammarstrom, L.,Bjorkander, J., Belohradsky, B.H., Casariego, G.F., Garcia Rodriguez, M.C., Conley, M.E.:
Clinical and molecular analysis of patients with defects in micro heavy chain gene.
J Clin Invest. 110(7), 1029-1035 (2002) - Impact Factor: 14.051.

Riedler, J., Braun-Fahrländer, C., Eder, W., Schreuer, M., Waser, M., Maisch, S., Carr, D., Schierl, R., Nowak, D., von Mutius, E.:
Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey.
Lancet. 358(9288), 1129-1133 (2001) - Impact Factor: 13.251.

Becker, B.C., Schuster, F.R., Ganster, B., Seidl, H.P., Schmid, I.:
Cutaneous mucormycosis in an immunocompromised patient.
Lancet Infect Dis. 6(8), 536 (2006) - Impact Factor: 11.808.

Zink, D., Amaral, M.D., Englmann, A., Lang, S., Clarke, L.A., Rudolph, C., Alt, F., Luther, K., Braz, C., Sadoni, N., Rosenecker, J., Schindelhauer, D.:
Transcription-dependent spatial arrangements of CFTR and adjacent genes in human cell nuclei.
J Cell Biol. 166(6), 815-825 (2004) - Impact Factor: 11.602.

Heller, C., Heinecke, A., Junker, R., Knöfler, R., Kosch, A., Kurnik, K., Schobess, R., von Eckardstein, A., Sträter, R., Zieger, B., Nowak-Göttl, U.:
Cerebral venous thrombosis in children: a multifactorial origin.
Circulation. 108(11), 1362-1367 (2003) - Impact Factor: 11.164.

Socie, G., Mary, J.Y., Schrezenmeier, H., Marsh, J., Bacigalupo, A., Locasciulli, A.,
Fuehrer, M., Bekassy, A., Tichelli, A., Passweg, J.:
Granulocyte-stimulating factor and severe aplastic anemia: a survey by the European Group for Blood and Marrow Transplantation (EBMT).
Blood. 109(7), 2794-2796 (2007) - Impact Factor: 10.896.

Schuster, I.G., Busch, D.H., Eppinger, E., Kremmer, E., Milosevic, S., Hennard, C., Kuttler, C., Ellwart, J.W., Frankenberger, B., Nössner, E., Salat, C., Bogner, C., Borkhardt, A., Kolb, H.J., Krackhardt, A.M.:
Allorestricted T cells with specificity for the FMNL1-derived peptide PP2 have potent antitumor activity against hematologic and other malignancies.
Blood. 110(8), 2931-2939 (2007) - Impact Factor: 10.896.

Schrezenmeier, H., Passweg, J.R., Marsh, J.C., Bacigalupo, A., Bredeson, C.N., Bullorsky, E., Camitta, B.M., Champlin, R.E., Gale, R.P., Fuhrer, M., Klein, J.P., Locasciulli, A., Oneto, R., Schattenberg, A.V., Socie, G., Eapen, M.:
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood. 110(4), 1397-1400 (2007) - Impact Factor: 10.896.

Jarius, S., Eichhorn, P., Albert, M.H., Wagenpfeil, S., Wick, M., Belohradsky, B.H., Hohlfeld, R., Jenne, D.E., Voltz, R.:
Intravenous immunoglobulins contain naturally occurring antibodies that mimic antineutrophil cytoplasmic antibodies and activate neutrophils in a TNFalpha-dependent and Fc-receptor-independent way.
Blood. 109(10), 4376-4382 (2007) - Impact Factor: 10.896.

Hönig, M., Albert, M.H., Schulz, A., Sparber-Sauer, M., Schütz, C., Belohradsky, B.H.,
Güngör, T., Rojewski, M.T., Bode, H., Pannicke, U., Lippold, D., Schwarz, K.,
Debatin, K.M., Hershfield, M.S., Friedrich, W.:
Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications.
Blood. 109(8), 3595-3602 (2007) - Impact Factor: 10.896.

Bufler, P., Azam, T., Gamboni-Robertson, F., Reznikov, L.L., Kumar, S., Dinarello, C.A., Kim, S.H.: 

A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity. 

Proc Natl Acad Sci U S A. 99(21), 13723-13728 (2002) - Impact Factor: 10.7.

Fuchs, U., Borkhardt, A.:
The Application of siRNA Technology to Cancer Biology Discovery.
Adv Cancer Res. 96 75-102 (2006) - Impact Factor: 10.682.

Holzinger, A., Maier, E M., Bück, C., Mayerhofer, P.U., Kappler, M., Haworth, J.C., Moroz, S.P., Hadorn, H.B., Sadler, J.E., Roscher, A.A.:
Mutations in the proenteropeptidase gene are the molecular cause of congenital enteropeptidase deficiency.
Am J Hum Genet. 70(1), 20-25 (2002) - Impact Factor: 10.649.

 

Unser Motto

"Helfen-Forschen-Heilen"

Unterstützen Sie uns!

Im Notfall

Newsletter Freundeskreis

International Patient Office

Russian

Tel.: +49 89 4400 72014 

Arabic

Tel: +49 89 4400 75147